MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $166 avg across 4 analysts.
Buy-rated share 44% → 47% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.17 | $1.09 | -6.8% |
| Apr 2026 | $1.11 | $1.27 | +14.4% |
| Feb 2026 | $1.11 | $1.08 | -2.7% |
| Oct 2025 | $1.03 | $1.13 | +9.7% |
| Jul 2025 | $0.98 | $1.04 | +6.1% |
| Apr 2025 | $1.07 | $1.06 | -0.9% |
| Feb 2025 | $0.89 | $0.94 | +5.5% |
| Oct 2024 | $0.93 | $0.90 | -3.2% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $840M— | $920M+9.5% | $922M+0.2% | $981M+6.4% | $1.2B+26.7% |
| EPS (dil.) | $3.17— | $3.81+20.2% | $3.94+3.4% | $3.60-8.6% | $4.43+23.1% |
| Free Cash Flow | $432M— | $387M-10.4% | $26M-93.3% | $413M+1488.5% | $441M+6.8% |
| Gross Margin | 52.7% | 52.5%-0.2pp | 53.7%+1.2pp | 53.8%+0.1pp | 73.5%+19.7pp |
| Operating Margin | 49.9% | 49.5%-0.4pp | 50.7%+1.2pp | 49.8%-0.8pp | 49.4%-0.5pp |
| Net Margin | 36.5% | 40.2%+3.7pp | 41.6%+1.4pp | 36.1%-5.6pp | 35.5%-0.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$6K over 180 days (4 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 15.8%/yr (revenue basis).
Base free cash flow $293M (avg FY2023–FY2025; latest year $441M) · equity value $13.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 51 for DTM suggests a neutral outlook, driven by a mix of factors. The stock scores high on growth, with revenue growth of 26.7% and EPS growth of 23.1%, and exhibits strong profitability, with an operating margin of 49.7%. However, it trades at a premium, with a P/E of 29.4, contributing to a lower value score, while momentum is somewhat muted due to a recent 3-month decline of 7.4%. The long-term and short-term scores are relatively aligned, with only a 4-point difference.